Literature DB >> 26222078

The Contribution of Angiogenesis to the Process of Metastasis.

Diane R Bielenberg1, Bruce R Zetter.   

Abstract

The role of angiogenesis in tumor growth has been studied continuously for over 45 years. It is now appreciated that angiogenesis is also essential for the dissemination and establishment of tumor metastases. In this review, we focus on the role of angiogenesis as a necessity for the escape of tumor cells into the bloodstream and for the establishment of metastatic colonies in secondary sites. We also discuss the role of tumor lymphangiogenesis as a means of dissemination of lymphatic metastases. Appropriate combination therapies may be used in the future to both prevent and treat metastatic disease through the rational use of antiangiogenic and antilymphangiogenic therapies in ways that are informed by the current and future work in the field.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26222078      PMCID: PMC4670555          DOI: 10.1097/PPO.0000000000000138

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  79 in total

1.  Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic.

Authors:  R S Kerbel; G Klement; K I Pritchard; B Kamen
Journal:  Ann Oncol       Date:  2002-01       Impact factor: 32.976

Review 2.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Authors:  Lynn Hlatky; Philip Hahnfeldt; Judah Folkman
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

Review 3.  Lymphatic vasculature development.

Authors:  Guillermo Oliver
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

Review 4.  Clinical translation of angiogenesis inhibitors.

Authors:  Robert Kerbel; Judah Folkman
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 5.  Angiogenesis inhibitors: a new class of drugs.

Authors:  Judah Folkman
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

6.  Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.

Authors:  W D Beecken; A Fernandez; A M Joussen; E G Achilles; E Flynn; K M Lo; S D Gillies; K Javaherian; J Folkman; Y Shing
Journal:  J Natl Cancer Inst       Date:  2001-03-07       Impact factor: 13.506

Review 7.  The seed and soil hypothesis: vascularisation and brain metastases.

Authors:  Isaiah J Fidler; Seiji Yano; Ruo-Dan Zhang; Takahashi Fujimaki; Corazon D Bucana
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

8.  Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.

Authors:  T Hawighorst; P Velasco; M Streit; Y K Hong; T R Kyriakides; L F Brown; P Bornstein; M Detmar
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

9.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 10.  Role of angiogenesis in tumor growth and metastasis.

Authors:  Judah Folkman
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

View more
  125 in total

1.  A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.

Authors:  Jin-Cherng Lien; Chi-Li Chung; Tur-Fu Huang; Tsung-Chia Chang; Kuan-Chung Chen; Ging-Yan Gao; Ming-Jen Hsu; Shiu-Wen Huang
Journal:  Br J Pharmacol       Date:  2019-09-15       Impact factor: 8.739

2.  Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.

Authors:  Maryam Farzaneh Behelgardi; Saber Zahri; Zahra Gholami Shahvir; Farhad Mashayekhi; Laleh Mirzanejad; S Mohsen Asghari
Journal:  Mol Biol Rep       Date:  2020-02-18       Impact factor: 2.316

3.  IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.

Authors:  Tatiana Correa Carneiro-Lobo; Luiza Coimbra Scalabrini; Leila da Silva Magalhães; Laura B Cardeal; Felipe Silva Rodrigues; Edmilson Ozorio Dos Santos; Albert S Baldwin; Elena Levantini; Ricardo J Giordano; Daniela Sanchez Bassères
Journal:  Lung Cancer       Date:  2019-02-25       Impact factor: 5.705

4.  MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.

Authors:  Yu Li; Huibiao Zhang; Lei Fan; Jiahui Mou; Yue Yin; Chao Peng; Yuxiang Chen; Henglei Lu; Liting Zhao; Zhouteng Tao; Jing Chen; Yizheng Wang; Xinming Qi; Ruimin Huang; Jin Ren
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

5.  System configuration optimization for mesoscopic fluorescence molecular tomography.

Authors:  Fugang Yang; Denzel Faulkner; Ruoyang Yao; Mehmet S Ozturk; Qinglan Qu; Xavier Intes
Journal:  Biomed Opt Express       Date:  2019-10-11       Impact factor: 3.732

Review 6.  Exploring the molecular role of endostatin in diabetic neuropathy.

Authors:  Tuhin Mukherjee; Tapan Behl; Aayush Sehgal; Saurabh Bhatia; Harmanpreet Singh; Simona Bungau
Journal:  Mol Biol Rep       Date:  2021-02-09       Impact factor: 2.316

Review 7.  Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation.

Authors:  Manuel U Ramirez; Elizabeth R Stirling; Nancy J Emenaker; David D Roberts; David R Soto-Pantoja
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

8.  The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.

Authors:  Narine Ghazaryan; Naira Movsisyan; Joana Catarina Macedo; Sara Vaz; Naira Ayvazyan; Luis Pardo; Elsa Logarinho
Journal:  Invest New Drugs       Date:  2019-01-25       Impact factor: 3.850

Review 9.  Mechanosensitive Ion Channels: TRPV4 and P2X7 in Disseminating Cancer Cells.

Authors:  Jacob M Hope; Joshua D Greenlee; Michael R King
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

Review 10.  Vascularized Biomaterials to Study Cancer Metastasis.

Authors:  Katharine R Bittner; Juan M Jiménez; Shelly R Peyton
Journal:  Adv Healthc Mater       Date:  2020-01-24       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.